Development and validation of a new prognostic score of death for patients with hepatocellular carcinoma in palliative setting

Journal of Hepatology

Volumn 54, Issue 1, 2011, Pages 108-114

  Tournoux Facon, Caroline ^a   Paoletti, Xavier ^b,c   Barbare, Jean Claude ^d   Bouché, Olivier ^e   Rougier, Philippe ^f   Dahan, Laetitia ^g   Lombard Bohas, Catherine ^h   Faroux, Roger ⁱ   Raoul, Jean Luc ^j   Bedenne, Laurent ^k   Bonnetain, Franck ^k  

^a UNIVERSITÉ DE POITIERS   (France)

^b INSTITUT CURIE   (France)

^c INSERM U900   (France)

^d AMIENS UNIVERSITY HOSPITAL   (France)

^e REIMS UNIVERSITY HOSPITAL   (France)

^f HÔPITAL AMBROISE PARÉ   (France)

^g TIMONE HOSPITAL   (France)

^h Service d'Hépatogastroentérologie   (France)

ⁱ Service d'Hépato Gastroentérologie   (France)

^j European University in Brittany   (France)

^k Chu   (France)

more..

Author keywords

Discrimination; Overall survival; Palliative setting; Prognostic factors

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN;

AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE METASTASIS; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN OBSTRUCTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; WORLD HEALTH ORGANIZATION;

AGED; ALKALINE PHOSPHATASE; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; FEMALE; FRANCE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PALLIATIVE CARE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 78649630146     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.06.015     Document Type: Article

References (27)

1. K. Okuda, T. Ohtsuki, H. Obata, M. Tomimatsu, N. Okazaki, and H. Hasegawa Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients Cancer 56 1985 918 928
2. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 1998;28:751-55.
3. S. Ueno, G. Tanabe, K. Sako, T. Hiwaki, H. Hokotate, and Y. Fukukura Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program Hepatology 34 2001 529 534
4. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators. Hepatology 2000;31:840-45.
5. J.M. Llovet, C. Bru, and J. Bruix Prognosis of hepatocellular carcinoma: the BCLC staging classification Semin Liver Dis 19 1999 329 338
6. S. Chevret, J.C. Trinchet, D. Mathieu, A.A. Rached, M. Beaugrand, and C. Chastang A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'etude et de traitement du carcinome hepatocellulaire J Hepatol 31 1999 133 141
7. Y.H. Huang, C.H. Chen, T.T. Chang, S.C. Chen, S.Y. Wang, and H.S. Lee Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery J Gastroenterol Hepatol 20 2005 765 771
8. I. Levy, and M. Sherman Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto Gut 50 2002 881 885
9. S. Wildi, B.C. Pestalozzi, L. McCormack, and P.A. Clavien Critical evaluation of the different staging systems for hepatocellular carcinoma Br J Surg 91 2004 400 408
10. Pepe M. the statistical evaluation of medical tests for classification and prediction. Oxford Statistical University 2003.
11. S. Collette, F. Bonnetain, X. Paoletti, M. Doffoel, O. Bouche, and J.L. Raoul Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials Ann Oncol 19 2008 1117 1126
12. J.C. Barbare, O. Bouche, F. Bonnetain, L. Dahan, C. Lombard-Bohas, and R. Faroux Treatment of advanced hepatocellular carcinoma with long-acting octreotide: a phase III multicentre, randomised, double blind placebo-controlled study Eur J Cancer 45 2009 1788 1797
13. J.C. Barbare, O. Bouche, F. Bonnetain, J.L. Raoul, P. Rougier, and A. Abergel Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma J Clin Oncol 23 2005 4338 4346
14. V. Mazzaferro, E. Regalia, R. Doci, S. Andreola, A. Pulvirenti, and F. Bozzetti Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
15. M. Soresi, C. Magliarisi, P. Campagna, G. Leto, G. Bonfissuto, and A. Riili Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma Anticancer Res 23 2003 1747 1753
16. M. Schemper Predictive accuracy and explained variation Stat Med 22 2003 2299 2308
17. P. Royston, and W. Sauerbrei A new measure of prognostic separation in survival data Stat Med 23 2004 723 748
18. F.E. Harrell Jr., K.L. Lee, and D.B. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387
19. U. Cillo, A. Vitale, F. Grigoletto, F. Farinati, A. Brolese, and G. Zanus Prospective validation of the Barcelona Clinic Liver Cancer staging system J Hepatol 44 2006 723 731
20. J.M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, and E. Gane Sorafenib in advanced hepatocellular carcinoma NEJM 359 4 2008 378 390
21. HAS/Service des recommandations professionnelles - service évaluation médico-économique et santé publique Septembre 2007.
22. Verslype C, Van Cutsem E, Dicato M, Arber N, Berlin JD, Cunningham D et al. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008. Ann Oncol. 2009;20:vii1-vii6.
23. F. Borie, B. Tretarre, A.M. Bouvier, J. Faivre, F. Binder, and G. Launoy Primitive liver cancers: epidemiology and geographical study in France Eur J Gastroenterol Hepatol 21 2009 984 989
24. J.A. Marrero Hepatocellular carcinoma Curr Opin Gastroenterol 19 2003 243 249
25. R. Wong, and D.A. Corley Racial and ethnic variations in hepatocellular carcinoma incidence within the United States Am J Med 121 2008 525 531
26. F. Trevisani, G. Magini, V. Santi, A.M. Morselli-Labate, M.C. Cantarini, and M.A. Di Nolfo Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance Am J Gastroenterol 102 2007 1022 1031
27. F. Bonnetain, X. Paoletti, S. Collette, M. Doffoel, O. Bouche, and J.L. Raoul Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials Qual Life Res 17 2008 831 843